EBMT 2019 | The success story of bispecific and trispecific antibodies

Name: The success story of bispecific and trispecific antibodies
Uploaded: 2019-03-25T17:49:29.000Z
Duration: 2 min
Description: Beyond CAR T-cell therapy, bispecific and trispecific antibodies prove to be promising, which Hermann Einsele, MD, FRCP University Hospital Würzburg, Würzburg, Germany, discusses at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Hermann Einsele • 25 Mar 2019

EBMT 2019

General Antibodies

Beyond CAR T-cell therapy, bispecific and trispecific antibodies prove to be promising, which Hermann Einsele, MD, FRCP University Hospital Würzburg, Würzburg, Germany, discusses at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.